Cascade AI | $3,750,000 | (Oct 25, 2024)
Mave | $1,444,304 | (Oct 25, 2024)
Outrider | $62,000,000 | (Oct 25, 2024)
Nuclera
United Kingdom
- Cambridge, Cambridgeshire
- 17/10/2024
- Unknown
- $75,000,000
At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow researchers to accelerate their protein projects. Fail fast, succeed faster.
Our eProtein Discovery™ system automates construct screening for the best soluble expression and purification yields of different proteins in under 24 hours. From there, protein scale-up happens the next day (up to the mg scale) right on the benchtop - delivering reliable protein in-hand in less than 48 hours. Nuclera’s technology integrates cell-free protein synthesis and digital microfluidics on smart cartridges, allowing rapid progress on protein projects through a benchtop, automated, high-throughput protein access system.
Founded in 2013 by PhD students at the University of Cambridge, the company now has a presence in Cambridge, UK and Boston, MA employing over 100 employees.
- Industry Biotechnology Research
- Website https://www.nuclera.com/
- LinkedIn https://www.linkedin.com/company/nuclera/
Related People
Michael ChenCo Founder
United Kingdom -
Greater Cambridge Area
You can reach me at mchen at nuclera.com
OLOID | $6,000,000 | (Oct 25, 2024)
MoneyStack | $250,000 | (Oct 25, 2024)
Attention | $14,000,000 | (Oct 25, 2024)
BuildPass | $7,500,000 | (Oct 25, 2024)
Aether Energy (YC W24) | $2,500,000 | (Oct 25, 2024)
Adden Energy | $15,000,000 | (Oct 24, 2024)
Genie AI | $17,190,848 | (Oct 24, 2024)
Valon | $100,000,000 | (Oct 24, 2024)
Fixify | $25,000,000 | (Oct 24, 2024)